Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Thoracic 2Genitourinary 2Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5744Lung Neoplasms 3716Small Cell Lung Carcinoma 1017Breast Neoplasms 667Neoplasms 616Colorectal Neoplasms 556Melanoma 479Ovarian Neoplasms 434Neoplasm Metastasis 431Pancreatic Neoplasms 386Stomach Neoplasms 332Carcinoma, Renal Cell 311Adenocarcinoma of Lung 308Squamous Cell Carcinoma of Head and Neck 304Head and Neck Neoplasms 293Prostatic Neoplasms 284Mesothelioma, Malignant 281Esophageal Neoplasms 265Mesothelioma 244Colonic Neoplasms 225Brain Neoplasms 216Urinary Bladder Neoplasms 212Triple Negative Breast Neoplasms 209Uterine Cervical Neoplasms 207Endometrial Neoplasms 174Sarcoma 171Carcinoma, Hepatocellular 158NSCLC 134Kidney Neoplasms 127Carcinoma 127

Interventions

S 3304 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neovascularization, Pathologic × Thoracic × Clear all
NCT00005655 2019-12-17

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
39 enrolled
BreastGenitourinarySarcomaThoracic

Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Neovascularization, Pathologic, Sarcoma

NCT00078390 2018-05-02

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Shionogi Inc.

Phase 1/2 Completed
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡